Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
The relationship between spot Bitcoin (CRYPTO: BTC) ETF flows and analyst coverage of crypto-exposed equities has become one of Wall Street’s most closely watched dynamics.
Robinhood Markets has been stuck in a negatively tilted consolidation pattern since October. However, this behavioral cue may also be setting up a bullish reversal in HOOD stock.
Immunome shares trade higher on Monday after the company announced results from the global pivotal Phase 3 RINGSIDE trial of varegcasetat and met its primary endpoint.
The SEC’s pivot on cryptocurrency enforcement after Donald Trump returned to office in January has sparked a heated debate between industry veterans and market observers.
The holiday season is here and retailers are expecting a trillion-dollar shopping season. Wall Street is watching value-driven and e-commerce retailers for investment opportunities.
Sanofi expands its partnership with Dren Bio in a deal featuring $100 million upfront and up to $1.7 billion tied to a next-generation autoimmune B-cell therapy.
Keybanc lowers ServiceNow rating during slowing SaaS growth, rising AI pressures, and potential loss of AI orchestration leadership to Microsoft in 2026.
Bank of America upgrades Bristol Myers to Buy, lifting its price target to $61 on pipeline catalysts, valuation support, and improving risk-reward outlook.
Wall Street traded little changed Monday after last Friday’s tech-led sell-off failed to trigger meaningful dip-buying interest. By midday trading in New York, major indexes hovered near flat levels as investors stayed cautious ahead of a dense macro calendar this week.
